世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

マイクロカテーテル市場：タイプ別（デリバリー、診断、吸引、ステアラブル）、デザイン別（シングル、デュアル）、用途別（心臓血管、神経血管、末梢血管、腫瘍）、エンドユーザー別（病院、外来手術センター）-2028年までの世界予測


Microcatheters Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2028

世界のマイクロカテーテル市場は、2023年の8億7,400万米ドルから2028年には11億4,200万米ドルに達し、予測期間中のCAGRは5.5％で成長すると予測されている。低侵襲性、正確なナビゲーション、標的治療など、マイ... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2023年7月7日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		225 160 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

世界のマイクロカテーテル市場は、2023年の8億7,400万米ドルから2028年には11億4,200万米ドルに達し、予測期間中のCAGRは5.5％で成長すると予測されている。低侵襲性、正確なナビゲーション、標的治療など、マイクロカテーテルが提供する利点の増加が、予測数年間の市場成長を押し上げると予想される主な要因である。

"ステアラブルマイクロカテーテルセグメントは2023-2028年の予測期間に最高のCAGRを記録する"
製品タイプに基づき、マイクロカテーテル市場はデリバリーマイクロカテーテル、吸引マイクロカテーテル、診断マイクロカテーテル、ステアラブルマイクロカテーテルに区分される。ステアラブルマイクロカテーテルセグメントは、2023-2028年の予測期間で最も高いCAGRを記録する。ステアラブルマイクロカテーテルは、インターベンショナルラジオロジー、神経血管インターベンション、末梢血管インターベンションなどの低侵襲手技でよく使用される。これらの処置は、従来の開腹手術に比べ、患者の外傷の軽減、入院期間の短縮、回復時間の短縮、医療費の削減などの利点がある。体内の複雑な血管系内をマイクロカテーテルで移動・操縦する能力は、正確で的を絞った治療を可能にし、ステアラブル・マイクロカテーテルの成長をさらに後押しする。

"神経血管用途セグメントは2023-2028年の予測期間に最も高いCAGRを記録する"
用途に基づき、マイクロカテーテル市場は心臓血管、神経血管、末梢血管、泌尿器、耳鼻咽喉科、その他の用途に区分される。材料、設計、コーティングの改良を含むマイクロカテーテル技術の継続的な進歩により、神経血管用マイクロカテーテルのナビゲーション能力と送達能力が向上している。これらの進歩により、医師は頭蓋内の困難な部位に、より高い精度と制御性で到達できるようになり、治療可能な病変の範囲が拡大し、手技の成果が向上する。政府、医療機関、研究機関は、神経血管医療インフラの改善に投資している。これには、高度な神経インターベンション・スイートの利用可能性や、マイクロカテーテルを含む最先端の神経血管器具の採用が含まれる。このような投資は、医療施設における神経血管マイクロカテーテルの成長と採用に寄与している。

"シングルルーメンマイクロカテーテルセグメントが2022-2028年のマイクロカテーテル市場で最大シェアを占める"
設計に基づき、マイクロカテーテル市場はシングルルーメンマイクロカテーテルとデュアル・マルチルーメンマイクロカテーテルに区分される。デュアルおよびマルチルーメンマイクロカテーテルセグメントの設計セグメントは、予測期間中、マイクロカテーテル市場で大きな市場シェアを占めると推定される。
デュアルおよびマルチルーメンマイクロカテーテルは、様々なインターベンション手技、特に低侵襲手術の分野で使用される医療機器である。複数のルーメン（流路）を持つ小型で柔軟なチューブで構成されており、流体、薬剤、医療器具を標的部位に同時に送達することができる。デュエルおよびマルチルーメンマイクロカテーテルを使用する利点は以下の通りである：
処置効率の向上：1本のカテーテルに複数のルーメンを組み込むことで、デュエルおよびマルチルーメン・マイクロカテーテルは複数回のカテーテル挿入の必要性を減らし、手技を合理化することができる。これにより時間を節約し、全体的な手技効率を向上させることができる。

"2022-2028年にマイクロカテーテル市場で最も高い成長率を記録するのは病院、外科センター、専門クリニックのセグメント"
マイクロカテーテル市場の主なエンドユーザーは、病院、手術センター＆専門クリニック、外来手術センターである。外来手術センターのエンドユーザー部門は、予測期間中、マイクロカテーテル市場で大きな市場シェアを占めると推定される。外来手術センターは、入院の必要性を最小限に抑える即日手術の提供に重点を置いている。マイクロカテーテルは、低侵襲手術を可能にする上で重要な役割を果たしており、従来の開腹手術に比べて回復時間が短く、痛みが軽減され、低コストであるため、ASCで好まれることが多い。
技術の進歩：マイクロカテーテル技術の進歩により、これらの器具はより汎用性が高く、信頼性が高く、使いやすいものとなっている。カテーテル素材の改良、柔軟性の向上、プロフィールの小型化により、複雑な解剖学的構造への正確なナビゲーションが可能になり、マイクロカテーテルはASCで行われるより幅広い手技に適している。

"アジア太平洋地域は予測期間中に市場で大きな成長を記録する"
2022年、APAC地域は予測期間中に市場で大きな成長を記録すると予想されている。アジア太平洋地域は、インド、中国、日本、オーストラリア、韓国、RoAPACで構成されている。アジア太平洋（APAC）地域は、マイクロカテーテルの市場が大幅に増加している。この成長にはいくつかの要因が寄与している：
APAC諸国では、経済成長、人口増加、医療へのアクセス向上などを背景に、医療費の増加が続いている。このため、低侵襲手技をサポートし、患者の予後を改善するために、マイクロカテーテルを含む先進医療技術への投資が拡大している。
APAC地域は高齢化人口が多く、慢性疾患にかかりやすく、専門的な医療介入が必要である。マイクロカテーテルは、心血管疾患、神経血管障害、その他の加齢関連疾患の管理に広く使用されている。高齢化人口の増加がAPACにおけるマイクロカテーテルの需要を煽っている。
APAC諸国では、心血管疾患、癌、神経血管障害などの慢性疾患の有病率が上昇している。マイクロカテーテルはこれらの疾患の診断、治療、管理において重要な役割を担っており、同地域における同デバイスの需要増につながっている。

本レポートで参照した主な参加企業の内訳は以下の通りである：
- 企業タイプ別ティア1-30％、ティア2-42％、ティア3-28
- 役職別Cレベル-10%、ディレクターレベル-76%、その他-14
- 地域別北米-40%、欧州-30%、アジア太平洋地域-22%、中南米-6%、中東・アフリカ-2

マイクロカテーテル市場における有力企業は、テルモ株式会社（日本、東京）、ボストン・サイエンティフィック社（米国、マサチューセッツ州）、クック・メディカル社（米国、インディアナ州）などである。

調査範囲

この調査レポートは、マイクロカテーテル市場を製品、タイプ、用途、エンドユーザー、地域別に調査しています。また、市場成長に影響を与える要因を網羅し、市場における様々な機会と課題を分析し、市場リーダー向けの競争環境の詳細を提供しています。さらに、個々の成長動向に関してミクロ市場を分析し、主要5地域（およびこれらの地域のそれぞれの国）に関して市場セグメントの収益を予測しています。マイクロカテーテル市場の成長に影響を与える促進要因、阻害要因、課題、機会などの主要要因に関する詳細情報を網羅しています。
主要な業界プレイヤーを詳細に分析し、事業概要、ソリューション、サービス、主要戦略、契約、パートナーシップ、協定、新製品・サービスの発表、M&A、マイクロカテーテル市場に関連する最近の動向などに関する洞察を提供しています。マイクロカテーテル市場のエコシステムにおける今後の新興企業の競争分析もカバーしています。
レポート購入の主な利点

本レポートは、マイクロカテーテル市場全体およびサブセグメントの収益数の最も近い近似値に関する情報を提供することで、本市場の市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、自社のビジネスをより良く位置づけ、適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、当レポートは、市場の脈拍を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報を関係者に提供するのに役立ちます。
本レポートでは、以下のポイントに関する洞察を提供しています：
- マイクロカテーテル市場の成長に影響を与える主な促進要因（慢性疾患の有病率の増加、高齢化人口の増加、低侵襲技術の進歩）、阻害要因（厳しい規制要件、マイクロカテーテルの高コスト、発展途上地域での限定的な入手可能性）、機会（技術の進歩、低侵襲手技の採用増加）、課題（コスト圧力、製品の複雑性とばらつき）の分析
- 製品開発/イノベーション：マイクロカテーテル市場における今後の技術、研究開発活動、新製品・サービスの発売に関する詳細な洞察。
- 市場開発：有利な市場に関する包括的情報 - 当レポートでは、さまざまな地域のマイクロカテーテル市場を分析しています。
- 市場の多様化：マイクロカテーテル市場における新製品、未開拓地域、最近の開発、投資に関する詳細な情報
- 競合評価：テルモ株式会社（日本、東京）、ボストン・サイエンティフィック社（米国、マサチューセッツ州）、クックメディカル社（米国、インディアナ州）などの主要企業の市場シェア、成長戦略、サービス内容を詳細に評価します。

ページTOPに戻る


目次

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 MARKET SCOPE 26
1.3.1 MARKETS COVERED 26
1.3.2 REGIONS COVERED 26
1.3.3 INCLUSIONS AND EXCLUSIONS 27
1.3.4 YEARS CONSIDERED 27
1.4 CURRENCY CONSIDERED 27
1.5 RESEARCH LIMITATIONS 27
1.6 MARKET STAKEHOLDERS 28
1.7 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 1 RESEARCH DESIGN: MICROCATHETERS MARKET 29
FIGURE 2 RESEARCH DESIGN 30
2.1.1 SECONDARY DATA 30
FIGURE 3 KEY DATA FROM SECONDARY SOURCES 32
2.1.2 PRIMARY DATA 32
2.1.2.1 Primary sources 32
2.1.2.2 Key industry insights 33
2.1.2.3 Breakdown of primaries 34
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 34
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34
2.2 MARKET SIZE ESTIMATION 35
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 36
2.2.1 BOTTOM-UP APPROACH 36
2.2.1.1 Approach 1: Company revenue estimation approach 37
FIGURE 7 MICROCATHETERS MARKET: COMPANY REVENUE ESTIMATION APPROACH 37
2.2.1.2 Approach 2: Customer-based market estimation approach 38
FIGURE 8 MICROCATHETERS MARKET: CUSTOMER-BASED MARKET SIZE ESTIMATION APPROACH 38
2.2.1.3 Approach 3: Top-down approach 39
FIGURE 9 MICROCATHETERS MARKET: TOP-DOWN APPROACH 39
2.2.1.4 Approach 4: Primary interviews 39
 
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 40
FIGURE 10 DATA TRIANGULATION METHODOLOGY 41
2.4 MARKET SHARE ASSESSMENT 41
2.5 STUDY ASSUMPTIONS 42
2.6 GROWTH RATE ASSUMPTIONS 42
2.7 RISK ASSESSMENT 42
TABLE 1 MICROCATHETERS MARKET: RISK ASSESSMENT 42
3 EXECUTIVE SUMMARY 43
FIGURE 11 MICROCATHETERS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 43
FIGURE 12 MICROCATHETERS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 44
FIGURE 13 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2023 VS. 2028 (USD MILLION) 45
FIGURE 14 MICROCATHETERS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 45
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET 46
4 PREMIUM INSIGHTS 48
4.1 MICROCATHETERS MARKET OVERVIEW 48
FIGURE 16 INCREASING GERIATRIC POPULATION AND GROWING R&D INVESTMENTS
BY GOVERNMENT TO DRIVE MARKET 48
4.2 MICROCATHETERS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 49
FIGURE 17 DELIVERY MICROCATHETERS TO DOMINATE MICROCATHETERS
MARKET IN 2028 49
4.3 MICROCATHETERS MARKET, BY REGION AND END USER, 2022 (USD MILLION) 50
FIGURE 18 HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS SEGMENT DOMINATED MICROCATHETERS MARKET IN 2022 50
4.4 GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET 51
FIGURE 19 INDIA TO BE FASTEST GROWING COUNTRY IN GLOBAL MICROCATHETERS MARKET DURING STUDY PERIOD 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 20 MICROCATHETERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 52
5.2.1 DRIVERS 53
5.2.1.1 Rising target patient population suffering from chronic diseases globally 53
FIGURE 21 NUMBER OF NEW CANCER CASES (GLOBAL), BY CANCER SITE (2018 VS. 2020) 53
5.2.1.2 Advancements in microcatheter technologies 54
5.2.1.3 Increase in government initiatives, healthcare funding, and health-related services 54
 
TABLE 2 NATIONAL AVERAGE MEDICARE REIMBURSEMENT CPT CODES, 2022 55
5.2.1.4 Increased preference for minimally invasive surgeries over traditional open surgeries 56
5.2.2 RESTRAINTS 56
5.2.2.1 Stringent regulatory guidelines in mature markets 56
5.2.2.2 High cost of microcatheters and budget constraints in healthcare facilities 57
5.2.3 OPPORTUNITIES 57
5.2.3.1 Expansion of key players in emerging economies 57
5.2.3.2 Rising healthcare expenditure across emerging economies 57
FIGURE 22 GOVERNMENT HEALTH EXPENDITURE (% OF GDP) 58
FIGURE 23 GOVERNMENT HEALTH EXPENDITURE [AS % OF GENERAL GOVERNMENT EXPENDITURE] 58
5.2.4 CHALLENGES 59
5.2.4.1 Availability of alternative technologies for catheterization 59
5.3 KEY STAKEHOLDERS AND BUYING CRITERIA 59
5.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 59
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROCATHETERS MARKET 59
TABLE 3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%) 59
5.4 PORTER’S FIVE FORCES ANALYSIS 60
TABLE 4 MICROCATHETERS MARKET: PORTER’S FIVE FORCES ANALYSIS 60
5.4.1 THREAT OF NEW ENTRANTS 60
5.4.2 THREAT OF SUBSTITUTES 60
5.4.3 BARGAINING POWER OF SUPPLIERS 61
5.4.4 BARGAINING POWER OF BUYERS 61
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 61
5.5 REGULATORY ANALYSIS 61
5.5.1 US 61
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 62
5.5.2 EUROPE 62
5.5.3 JAPAN 63
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 63
5.6 PRICING ANALYSIS 64
TABLE 7 PRICING ANALYSIS: MICROCATHETERS MARKET, 2023 (USD) 64
5.7 REIMBURSEMENT SCENARIO ANALYSIS 65
TABLE 8 CPT CODES FOR MAJOR MICROCATHETERS 65
5.8 ECOSYSTEM MAPPING 65
5.9 VALUE CHAIN ANALYSIS 65
5.9.1 RESEARCH & DEVELOPMENT 66
5.9.2 PROCUREMENT AND PRODUCT DEVELOPMENT 66
5.9.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES 66
FIGURE 25 VALUE CHAIN ANALYSIS: MICROCATHETERS MARKET 66
5.10 SUPPLY CHAIN ANALYSIS 67
5.10.1 PROMINENT COMPANIES 67
5.10.2 SMALL & MEDIUM-SIZED COMPANIES 67
5.10.3 END USERS 67
FIGURE 26 SUPPLY CHAIN ANALYSIS: MICROCATHETERS MARKET 67
5.11 PATENT ANALYSIS 67
TABLE 9 IMPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND) 68
TABLE 10 EXPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND) 69
5.12 TECHNOLOGY ANALYSIS 69
5.13 CASE STUDY ANALYSIS 70
TABLE 11 CASE STUDY: EMBOLIZATION FOR CHEST WALL HEMORRHAGE-DIREXION MICROCATHETER STORY 70
5.14 KEY CONFERENCES AND EVENTS IN 2023–2024 70
TABLE 12 DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2023–2024 70
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 71
FIGURE 27 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 71
5.16 IMPACT OF ECONOMIC RECESSION ON MICROCATHETERS MARKET 71
6 MICROCATHETERS MARKET, BY PRODUCT 73
6.1 INTRODUCTION 74
TABLE 13 MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 74
TABLE 14 MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 74
TABLE 15 MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 75
TABLE 16 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 75
6.2 DELIVERY MICROCATHETERS 75
6.2.1 INCREASING NUMBER OF TARGET INTERVENTIONAL PROCEDURES TO DRIVE MARKET 75
TABLE 17 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION) 76
TABLE 18 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 76
TABLE 19 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION) 77
TABLE 20 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY END USER, 2020–2028 (USD MILLION) 77
6.3 ASPIRATION MICROCATHETERS 78
6.3.1 GROWING BURDEN OF CARDIOVASCULAR DISEASES AND RELATED MEDICAL CONDITIONS TO DRIVE MARKET 78
TABLE 21 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS,
BY REGION, 2020–2028 (USD MILLION) 78
TABLE 22 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS,
BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 78
TABLE 23 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION) 79
TABLE 24 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS,
BY END USER, 2020–2028 (USD MILLION) 79
6.4 DIAGNOSTICS MICROCATHETERS 80
6.4.1 LARGE TARGET PATIENT POPULATION FOR VASCULAR DISEASES TO DRIVE MARKET 80
TABLE 25 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION) 80
TABLE 26 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 81
TABLE 27 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION) 81
TABLE 28 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY END USER, 2020–2028 (USD MILLION) 82
6.5 STEERABLE MICROCATHETERS 82
6.5.1 GROWING NUMBER OF IMAGE-GUIDED AND MINIMALLY INVASIVE MEDICAL PROCEDURES TO DRIVE MARKET 82
TABLE 29 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION) 83
TABLE 30 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 83
TABLE 31 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION) 84
TABLE 32 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY END USER, 2020–2028 (USD MILLION) 84
7 MICROCATHETERS MARKET, BY PRODUCT DESIGN 85
7.1 INTRODUCTION 86
TABLE 33 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 86
7.2 SINGLE-LUMEN MICROCATHETERS 86
7.2.1 INCREASING NUMBER OF TARGET MEDICAL PROCEDURES AND OPERATIONAL ADVANTAGES TO DRIVE MARKET 86
TABLE 34 MICROCATHETERS MARKET FOR SINGLE-LUMEN MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION) 87
7.3 DUAL AND MULTI-LUMEN MICROCATHETERS 87
7.3.1 IMPROVED SURGICAL PRECISION AND INCREASED ADOPTION IN COMPLEX VASCULAR PROCEDURES TO DRIVE MARKET 87
TABLE 35 MICROCATHETERS MARKET FOR DUAL AND MULTI-LUMEN MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION) 88
8 MICROCATHETERS MARKET, BY APPLICATION 89
8.1 INTRODUCTION 90
TABLE 36 MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 90
8.2 CARDIOVASCULAR APPLICATIONS 91
8.2.1 EFFECTIVE DEVICE PLACEMENT DURING MINIMALLY INVASIVE PROCEDURES AND CRITICAL CARDIAC SURGERIES TO DRIVE MARKET 91
TABLE 37 MICROCATHETERS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 91
8.3 NEUROVASCULAR APPLICATIONS 91
8.3.1 INCREASING INCIDENCE OF TARGET NEUROLOGICAL CONDITIONS TO DRIVE MARKET 91
TABLE 38 MICROCATHETERS MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 92
8.4 PERIPHERAL VASCULAR APPLICATIONS 92
8.4.1 RISING NUMBER OF DIAGNOSTIC AND INTERVENTIONAL PROCEDURES TO DRIVE MARKET 92
TABLE 39 MICROCATHETERS MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 93
8.5 UROLOGY APPLICATIONS 93
8.5.1 INCREASING PREVALENCE OF UROLOGICAL DISORDERS AND ADVANCEMENTS IN MINIMALLY INVASIVE TECHNIQUES TO DRIVE MARKET 93
TABLE 40 MICROCATHETERS MARKET FOR UROLOGY APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 94
8.6 ONCOLOGY APPLICATIONS 94
8.6.1 INCREASING CLINICAL RESEARCH ON MINIMALLY INVASIVE CANCER TREATMENT TO DRIVE MARKET 94
TABLE 41 MICROCATHETERS MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 95
8.7 OTOLARYNGOLOGY APPLICATIONS 95
8.7.1 INCREASED NEED FOR DELICATE ACCESS AND PRECISE NAVIGATION IN DIAGNOSIS TO DRIVE MARKET 95
TABLE 42 MICROCATHETERS MARKET FOR OTOLARYNGOLOGY APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 96
8.8 OTHER APPLICATIONS 96
TABLE 43 MICROCATHETERS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 97
9 MICROCATHETERS MARKET, BY END USER 98
9.1 INTRODUCTION 99
TABLE 44 MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 99
9.2 HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS 99
9.2.1 LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO DRIVE MARKET 99
TABLE 45 MICROCATHETERS MARKET FOR HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS, BY REGION, 2020–2028 (USD MILLION) 100
9.3 AMBULATORY CARE CENTERS 100
9.3.1 GROWING PATIENT SUBMISSIONS FOR DIAGNOSTIC PROCEDURES IN EMERGING ECONOMIES TO DRIVE MARKET 100
TABLE 46 MICROCATHETERS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2020–2028 (USD MILLION) 101
 
10 MICROCATHETERS MARKET, BY REGION 102
10.1 INTRODUCTION 103
TABLE 47 MICROCATHETERS MARKET, BY REGION, 2020–2028 (USD MILLION) 103
10.2 NORTH AMERICA 104
FIGURE 28 NORTH AMERICA: MICROCATHETERS MARKET SNAPSHOT 104
10.2.1 RECESSION IMPACT: NORTH AMERICA 105
TABLE 48 NORTH AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 105
TABLE 49 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 106
TABLE 50 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 106
TABLE 51 NORTH AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 107
TABLE 52 NORTH AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 107
10.2.2 US 108
10.2.2.1 US to dominate North American microcatheters market during forecast period 108
TABLE 53 US: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 108
10.2.3 CANADA 108
10.2.3.1 Increasing prevalence of target diseases and high demand for timely diagnosis to drive market 108
TABLE 54 CANADA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 109
10.3 EUROPE 109
10.4 RECESSION IMPACT: EUROPE 109
TABLE 55 EUROPE: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 110
TABLE 56 EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 110
TABLE 57 EUROPE: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 111
TABLE 58 EUROPE: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 111
TABLE 59 EUROPE: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 112
10.4.1 GERMANY 112
10.4.1.1 Increasing aging population and rising life expectancy to drive market 112
TABLE 60 GERMANY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 112
10.4.2 FRANCE 113
10.4.2.1 Significant evolution of healthcare sector and growth in geriatric population to drive market 113
TABLE 61 FRANCE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 113
10.4.3 UK 113
10.4.3.1 High burden of chronic diseases and large volumes of surgeries to drive market 113
TABLE 62 UK: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 114
10.4.4 ITALY 114
10.4.4.1 Increasing geriatric population to drive market 114
TABLE 63 ITALY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 114
10.4.5 SPAIN 115
10.4.5.1 Increasing technological developments in healthcare sector to drive market 115
TABLE 64 SPAIN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 115
10.4.6 REST OF EUROPE 115
TABLE 65 REST OF EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 116
10.5 ASIA PACIFIC 116
10.6 RECESSION IMPACT: ASIA PACIFIC 116
FIGURE 29 ASIA PACIFIC: MICROCATHETERS MARKET SNAPSHOT 117
TABLE 66 ASIA PACIFIC: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 118
TABLE 67 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 118
TABLE 68 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 118
TABLE 69 ASIA PACIFIC: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 119
TABLE 70 ASIA PACIFIC: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 119
10.6.1 JAPAN 119
10.6.1.1 Increasing geriatric population and surgical procedures to drive market 119
TABLE 71 JAPAN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 120
10.6.2 CHINA 120
10.6.2.1 Growing prevalence of chronic disorders and developing healthcare infrastructure to drive market 120
TABLE 72 CHINA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 121
10.6.3 INDIA 122
10.6.3.1 Increasing target patient population with rising availability of advanced surgical treatments to drive market 122
TABLE 73 INDIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 122
10.6.4 AUSTRALIA 122
10.6.4.1 Developing healthcare sector and increasing availability of advanced surgical treatments to drive market 122
TABLE 74 AUSTRALIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 123
10.6.5 SOUTH KOREA 123
10.6.5.1 Growing target patient population to drive market 123
TABLE 75 SOUTH KOREA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 123
10.6.6 REST OF ASIA PACIFIC 124
TABLE 76 REST OF ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 124
10.7 LATIN AMERICA 124
10.8 RECESSION IMPACT: LATIN AMERICA 125
TABLE 77 LATIN AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 125
TABLE 78 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 125
TABLE 79 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 126
TABLE 80 LATIN AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 126
TABLE 81 LATIN AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 127
10.8.1 BRAZIL 127
10.8.1.1 Developing healthcare sector and increasing availability of advanced surgical treatments to drive market 127
TABLE 82 BRAZIL: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 127
10.8.2 MEXICO 128
10.8.2.1 Favorable government initiatives and rapidly growing healthcare sector to drive market 128
TABLE 83 MEXICO: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 128
10.9 MIDDLE EAST & AFRICA 128
10.9.1 INCREASING FOCUS OF MARKET PLAYERS AND ONGOING ECONOMIC GROWTH TO DRIVE MARKET 128
10.10 RECESSION IMPACT: MIDDLE EAST & AFRICA 129
TABLE 84 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 129
TABLE 85 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 130
TABLE 86 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 130
TABLE 87 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 131
 
11 COMPETITIVE LANDSCAPE 132
11.1 OVERVIEW 132
11.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS 132
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MICROCATHETERS MARKET 133
TABLE 88 OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MICROCATHETERS MARKET 133
11.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS 134
FIGURE 30 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN MICROCATHETERS MARKET 135
11.4 MARKET RANKING ANALYSIS 135
FIGURE 31 MICROCATHETERS MARKET RANKING, BY KEY PLAYER (2022) 136
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 138
11.5.1 STARS 138
11.5.2 EMERGING LEADERS 138
11.5.3 PERVASIVE PLAYERS 138
11.5.4 PARTICIPANTS 138
FIGURE 32 MICROCATHETERS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 139
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 140
11.6.1 PROGRESSIVE COMPANIES 140
11.6.2 STARTING BLOCKS 140
11.6.3 RESPONSIVE COMPANIES 140
11.6.4 DYNAMIC COMPANIES 140
FIGURE 33 MICROCATHETERS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/ SMES, 2022 141
11.7 COMPANY FOOTPRINT 142
TABLE 89 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN MICROCATHETERS MARKET 142
TABLE 90 COMPANY PRODUCT FOOTPRINT 143
TABLE 91 COMPANY GEOGRAPHICAL FOOTPRINT 144
11.8 COMPETITIVE SCENARIOS AND TRENDS 145
TABLE 92 KEY PRODUCT LAUNCHES 145
TABLE 93 KEY DEALS 146
TABLE 94 OTHER KEY DEVELOPMENTS 147
12 COMPANY PROFILES 148
12.1 KEY PLAYERS 148
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 MEDTRONIC 148
TABLE 95 MEDTRONIC: COMPANY OVERVIEW 148
FIGURE 34 MEDTRONIC: COMPANY SNAPSHOT (2022) 149
12.1.2 BOSTON SCIENTIFIC CORPORATION 152
TABLE 96 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 152
FIGURE 35 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 153
12.1.3 TERUMO MEDICAL CORPORATION 157
TABLE 97 TERUMO MEDICAL CORPORATION: COMPANY OVERVIEW 157
FIGURE 36 TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT (2022) 158
12.1.4 TELEFLEX INCORPORATED 162
TABLE 98 TELEFLEX INCORPORATED: COMPANY OVERVIEW 162
FIGURE 37 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022) 163
12.1.5 MERIT MEDICAL SYSTEMS, INC. 167
TABLE 99 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW 167
FIGURE 38 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2022) 168
12.1.6 ASAHI INTECC CO., LTD. 171
TABLE 100 ASAHI INTECC CO., LTD.: COMPANY OVERVIEW 171
FIGURE 39 ASAHI INTECC CO., LTD.: COMPANY SNAPSHOT (2022) 172
12.1.7 STRYKER 175
TABLE 101 STRYKER: COMPANY OVERVIEW 175
FIGURE 40 STRYKER: COMPANY SNAPSHOT (2022) 176
12.1.8 SURMODICS, INC. 178
TABLE 102 SURMODICS, INC.: COMPANY OVERVIEW 178
FIGURE 41 SURMODICS, INC.: COMPANY SNAPSHOT (2022) 179
12.1.9 CARDINAL HEALTH, INC. 181
TABLE 103 CARDINAL HEALTH, INC.: COMPANY OVERVIEW 181
FIGURE 42 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022) 182
12.1.10 JOHNSON & JOHNSON 184
TABLE 104 JOHNSON & JOHNSON: COMPANY OVERVIEW 184
FIGURE 43 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022) 185
12.1.11 GUERBET LLC 188
TABLE 105 GUERBET LLC: COMPANY OVERVIEW 188
FIGURE 44 GUERBET LLC: COMPANY SNAPSHOT (2022) 189
12.1.12 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD 191
TABLE 106 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW 191
FIGURE 45 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT (2022) 192
12.1.13 BECTON, DICKINSON AND COMPANY 194
TABLE 107 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 194
FIGURE 46 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 195
12.1.14 PENUMBRA, INC. 197
TABLE 108 PENUMBRA, INC.: COMPANY OVERVIEW 197
FIGURE 47 PENUMBRA, INC.: COMPANY SNAPSHOT (2022) 198
12.1.15 KANEKA CORPORATION 200
TABLE 109 KANEKA CORPORATION: COMPANY OVERVIEW 200
FIGURE 48 KANEKA CORPORATION: COMPANY SNAPSHOT (2022) 201
12.1.16 ANGIODYNAMICS, INC. 203
TABLE 110 ANGIODYNAMICS, INC.: COMPANY OVERVIEW 203
FIGURE 49 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT (2022) 204
12.1.17 BIOCARDIA INC. 206
TABLE 111 BIOCARDIA INC.: COMPANY OVERVIEW 206
12.2 OTHER PLAYERS 208
12.2.1 MILLAR, INC. 208
12.2.2 BAYLIS MEDICAL COMPANY, INC. 209
12.2.3 EMBOLX, INC. 210
12.2.4 ACANDIS GMBH 211
12.2.5 ACROSTAK 212
12.2.6 COOK MEDICAL 213
12.2.7 REFLOW MEDICAL, INC. 214
12.2.8 TZ MEDICAL, INC. 215
12.2.9 ORBUSNEICH MEDICAL 216
12.2.10 SPARTAN MICRO, INC. 217
12.2.11 TRANSIT SCIENTIFIC 218
12.2.12 TOKAI MEDICAL PRODUCTS 219
12.2.13 LIBATAPE PHARMACEUTICAL CO., LTD 220
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 221
13.1 DISCUSSION GUIDE 221
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 227
13.3 CUSTOMIZATION OPTIONS 229
13.4 RELATED REPORTS 229
13.5 AUTHOR DETAILS 230

　

ページTOPに戻る


　

Summary

The global microcatheter market is projected to reach USD 1,142 million by 2028 from USD 874 million in 2023, growing at a CAGR of 5.5% during the forecast period. The rise in advantages offered by microcatheter like Minimally Invasive, precise navigation, and targeted therapy among several others to be used are major factors anticipated to boost the market growth in the forecasting years.

“Steerable Microcatheters segment to register highest CAGR over the forecast period of 2023-2028”
Based on the product type, the microcatheter market is segmented into Delivery Microcatheter, Aspiration Microcatheter, Diagnostic Microcatheter, and Steerable Microcatheter. Steerable Microcatheters segment to register a highest CAGR over the forecast period of 2023-2028. Steerable microcatheters are often used in minimally invasive procedures, such as interventional radiology, neurovascular interventions, and peripheral vascular interventions. These procedures offer advantages over traditional open surgeries, including reduced patient trauma, shorter hospital stays, faster recovery times, and lower healthcare costs. The ability to navigate and steer microcatheters within the body's intricate vasculature allows for precise and targeted treatments, further supporting the growth of steerable microcatheters.

“The Neurovascular application segment to register highest CAGR over the forecast period of 2023-2028”
Based on the application, the Microcatheters market is segmented into Cardiovascular, Neurovascular, Peripheral Vascular, Urology, Otolaryngology, and other applications. Ongoing advancements in microcatheter technology, including improvements in materials, designs, and coatings, enhance the navigational capabilities and deliverability of neurovascular microcatheters. These advancements enable physicians to reach challenging intracranial locations with greater precision and control, expanding the range of treatable lesions and improving procedural outcomes. Governments, healthcare organizations, and research institutions are investing in improving neurovascular healthcare infrastructure. This includes the availability of advanced neuro-interventional suites and the adoption of state-of-the-art neurovascular devices, including microcatheters. Such investments contribute to the growth and adoption of neurovascular microcatheters in medical facilities.

“The single-lumen microcatheter segment accounted for the largest share of the microcatheter market in 2022-2028”
Based on the design, the microcatheter market is segmented into single-lumen microcatheter and Dual and Multi-lumen Microcatheter. The dual and multi-lumen microcatheter segment design segment is estimated to hold a significant market share of the microcatheter market during the forecast period.
Duel and multi-lumen microcatheters are medical devices used in various interventional procedures, particularly in the field of minimally invasive surgery. They consist of small, flexible tubes with multiple lumens (channels) that allow the simultaneous delivery of fluids, medications, and medical instruments to the target site. The drivers for using duel and multi-lumen microcatheters include:
Enhanced Procedure Efficiency: By incorporating multiple lumens within a single catheter, duel and multi-lumen microcatheters can streamline procedures by reducing the need for multiple catheter insertions. This can save time and improve overall procedural efficiency.

“Hospitals, Surgical Centers, and Specialty Clinics’ segment to register for the highest growth rate of the microcatheters market in 2022-2028”
The major end users in the microcatheters market are hospitals, surgical centers & specialty clinics, and ambulatory surgical centers. The Ambulatory surgical center’s end-user segment is estimated to hold a significant market share of the microcatheter market during the forecast period. Ambulatory surgical centers focus on providing same-day surgical procedures that minimize the need for hospitalization. Microcatheters play a vital role in enabling minimally invasive procedures, which are often preferred in ASCs due to their shorter recovery times, reduced pain, and lower cost compared to traditional open surgeries.
Technological Advances: The advancements in microcatheter technology have made these devices more versatile, reliable, and user-friendly. Improved catheter materials, enhanced flexibility, and smaller profiles allow for precise navigation through complex anatomical structures, making microcatheters suitable for a broader range of procedures performed in ASCs.

“Asia Pacific to register significant growth in the market during the forecast period.”
In 2022, the APAC region is expected to register significant growth in the market during the forecast period. Asia Pacific comprises India, China, Japan, Australia, South Korea, and RoAPAC. The Asia-Pacific (APAC) region has witnessed a significant increase in the market for microcatheters. Several factors have contributed to this growth:
APAC countries have been experiencing rising healthcare expenditure, driven by economic growth, increasing population, and improved access to healthcare. This has led to greater investment in advanced medical technologies, including microcatheters, to support minimally invasive procedures and improve patient outcomes.
The APAC region has a large aging population, which is more prone to chronic diseases and requires specialized medical interventions. Microcatheters are extensively used in the management of cardiovascular diseases, neurovascular disorders, and other age-related conditions. The growing aging population has fueled the demand for microcatheters in APAC.
APAC countries have seen a rise in the prevalence of chronic diseases such as cardiovascular diseases, cancer, and neurovascular disorders. Microcatheters play a crucial role in the diagnosis, treatment, and management of these conditions, leading to an increased demand for these devices in the region.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
• By Designation: C-level–10%, Director-level–76%, and Others–14%
• By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and the Middle East & Africa–2%

Prominent players in the microcatheter market are Terumo Corporation (Tokyo, Japan), Boston Scientific Corporation (Massachusetts, US), and Cook Medical (Indiana, US), among others.

Research Coverage

This report studies the microcatheter market based on product, type, application, end-user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the microcatheters market.
A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the microcatheters market. Competitive analysis of upcoming startups in the microcatheters market ecosystem is covered in this report.
Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall microcatheters market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers (increasing prevalence of chronic diseases, growing aging population, advancements in minimally invasive techniques), restraints (stringent regulatory requirements, high cost of microcatheters, limited availability in developing regions), opportunities (technological advancements, increasing adoption of minimally invasive procedures), and challenges (cost pressures, product complexity and variability) influencing the growth of the microcatheters market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the microcatheters market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the microcatheters market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the microcatheters market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Terumo Corporation (Tokyo, Japan), Boston Scientific Corporation (Massachusetts, US), and Cook Medical (Indiana, US), among others.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 MARKET SCOPE 26
1.3.1 MARKETS COVERED 26
1.3.2 REGIONS COVERED 26
1.3.3 INCLUSIONS AND EXCLUSIONS 27
1.3.4 YEARS CONSIDERED 27
1.4 CURRENCY CONSIDERED 27
1.5 RESEARCH LIMITATIONS 27
1.6 MARKET STAKEHOLDERS 28
1.7 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 1 RESEARCH DESIGN: MICROCATHETERS MARKET 29
FIGURE 2 RESEARCH DESIGN 30
2.1.1 SECONDARY DATA 30
FIGURE 3 KEY DATA FROM SECONDARY SOURCES 32
2.1.2 PRIMARY DATA 32
2.1.2.1 Primary sources 32
2.1.2.2 Key industry insights 33
2.1.2.3 Breakdown of primaries 34
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 34
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34
2.2 MARKET SIZE ESTIMATION 35
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 36
2.2.1 BOTTOM-UP APPROACH 36
2.2.1.1 Approach 1: Company revenue estimation approach 37
FIGURE 7 MICROCATHETERS MARKET: COMPANY REVENUE ESTIMATION APPROACH 37
2.2.1.2 Approach 2: Customer-based market estimation approach 38
FIGURE 8 MICROCATHETERS MARKET: CUSTOMER-BASED MARKET SIZE ESTIMATION APPROACH 38
2.2.1.3 Approach 3: Top-down approach 39
FIGURE 9 MICROCATHETERS MARKET: TOP-DOWN APPROACH 39
2.2.1.4 Approach 4: Primary interviews 39
 
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 40
FIGURE 10 DATA TRIANGULATION METHODOLOGY 41
2.4 MARKET SHARE ASSESSMENT 41
2.5 STUDY ASSUMPTIONS 42
2.6 GROWTH RATE ASSUMPTIONS 42
2.7 RISK ASSESSMENT 42
TABLE 1 MICROCATHETERS MARKET: RISK ASSESSMENT 42
3 EXECUTIVE SUMMARY 43
FIGURE 11 MICROCATHETERS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 43
FIGURE 12 MICROCATHETERS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 44
FIGURE 13 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2023 VS. 2028 (USD MILLION) 45
FIGURE 14 MICROCATHETERS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 45
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET 46
4 PREMIUM INSIGHTS 48
4.1 MICROCATHETERS MARKET OVERVIEW 48
FIGURE 16 INCREASING GERIATRIC POPULATION AND GROWING R&D INVESTMENTS
BY GOVERNMENT TO DRIVE MARKET 48
4.2 MICROCATHETERS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 49
FIGURE 17 DELIVERY MICROCATHETERS TO DOMINATE MICROCATHETERS
MARKET IN 2028 49
4.3 MICROCATHETERS MARKET, BY REGION AND END USER, 2022 (USD MILLION) 50
FIGURE 18 HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS SEGMENT DOMINATED MICROCATHETERS MARKET IN 2022 50
4.4 GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET 51
FIGURE 19 INDIA TO BE FASTEST GROWING COUNTRY IN GLOBAL MICROCATHETERS MARKET DURING STUDY PERIOD 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 20 MICROCATHETERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 52
5.2.1 DRIVERS 53
5.2.1.1 Rising target patient population suffering from chronic diseases globally 53
FIGURE 21 NUMBER OF NEW CANCER CASES (GLOBAL), BY CANCER SITE (2018 VS. 2020) 53
5.2.1.2 Advancements in microcatheter technologies 54
5.2.1.3 Increase in government initiatives, healthcare funding, and health-related services 54
 
TABLE 2 NATIONAL AVERAGE MEDICARE REIMBURSEMENT CPT CODES, 2022 55
5.2.1.4 Increased preference for minimally invasive surgeries over traditional open surgeries 56
5.2.2 RESTRAINTS 56
5.2.2.1 Stringent regulatory guidelines in mature markets 56
5.2.2.2 High cost of microcatheters and budget constraints in healthcare facilities 57
5.2.3 OPPORTUNITIES 57
5.2.3.1 Expansion of key players in emerging economies 57
5.2.3.2 Rising healthcare expenditure across emerging economies 57
FIGURE 22 GOVERNMENT HEALTH EXPENDITURE (% OF GDP) 58
FIGURE 23 GOVERNMENT HEALTH EXPENDITURE [AS % OF GENERAL GOVERNMENT EXPENDITURE] 58
5.2.4 CHALLENGES 59
5.2.4.1 Availability of alternative technologies for catheterization 59
5.3 KEY STAKEHOLDERS AND BUYING CRITERIA 59
5.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 59
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROCATHETERS MARKET 59
TABLE 3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%) 59
5.4 PORTER’S FIVE FORCES ANALYSIS 60
TABLE 4 MICROCATHETERS MARKET: PORTER’S FIVE FORCES ANALYSIS 60
5.4.1 THREAT OF NEW ENTRANTS 60
5.4.2 THREAT OF SUBSTITUTES 60
5.4.3 BARGAINING POWER OF SUPPLIERS 61
5.4.4 BARGAINING POWER OF BUYERS 61
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 61
5.5 REGULATORY ANALYSIS 61
5.5.1 US 61
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 62
5.5.2 EUROPE 62
5.5.3 JAPAN 63
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 63
5.6 PRICING ANALYSIS 64
TABLE 7 PRICING ANALYSIS: MICROCATHETERS MARKET, 2023 (USD) 64
5.7 REIMBURSEMENT SCENARIO ANALYSIS 65
TABLE 8 CPT CODES FOR MAJOR MICROCATHETERS 65
5.8 ECOSYSTEM MAPPING 65
5.9 VALUE CHAIN ANALYSIS 65
5.9.1 RESEARCH & DEVELOPMENT 66
5.9.2 PROCUREMENT AND PRODUCT DEVELOPMENT 66
5.9.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES 66
FIGURE 25 VALUE CHAIN ANALYSIS: MICROCATHETERS MARKET 66
5.10 SUPPLY CHAIN ANALYSIS 67
5.10.1 PROMINENT COMPANIES 67
5.10.2 SMALL & MEDIUM-SIZED COMPANIES 67
5.10.3 END USERS 67
FIGURE 26 SUPPLY CHAIN ANALYSIS: MICROCATHETERS MARKET 67
5.11 PATENT ANALYSIS 67
TABLE 9 IMPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND) 68
TABLE 10 EXPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND) 69
5.12 TECHNOLOGY ANALYSIS 69
5.13 CASE STUDY ANALYSIS 70
TABLE 11 CASE STUDY: EMBOLIZATION FOR CHEST WALL HEMORRHAGE-DIREXION MICROCATHETER STORY 70
5.14 KEY CONFERENCES AND EVENTS IN 2023–2024 70
TABLE 12 DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2023–2024 70
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 71
FIGURE 27 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 71
5.16 IMPACT OF ECONOMIC RECESSION ON MICROCATHETERS MARKET 71
6 MICROCATHETERS MARKET, BY PRODUCT 73
6.1 INTRODUCTION 74
TABLE 13 MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 74
TABLE 14 MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 74
TABLE 15 MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 75
TABLE 16 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 75
6.2 DELIVERY MICROCATHETERS 75
6.2.1 INCREASING NUMBER OF TARGET INTERVENTIONAL PROCEDURES TO DRIVE MARKET 75
TABLE 17 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION) 76
TABLE 18 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 76
TABLE 19 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION) 77
TABLE 20 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY END USER, 2020–2028 (USD MILLION) 77
6.3 ASPIRATION MICROCATHETERS 78
6.3.1 GROWING BURDEN OF CARDIOVASCULAR DISEASES AND RELATED MEDICAL CONDITIONS TO DRIVE MARKET 78
TABLE 21 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS,
BY REGION, 2020–2028 (USD MILLION) 78
TABLE 22 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS,
BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 78
TABLE 23 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION) 79
TABLE 24 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS,
BY END USER, 2020–2028 (USD MILLION) 79
6.4 DIAGNOSTICS MICROCATHETERS 80
6.4.1 LARGE TARGET PATIENT POPULATION FOR VASCULAR DISEASES TO DRIVE MARKET 80
TABLE 25 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION) 80
TABLE 26 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 81
TABLE 27 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION) 81
TABLE 28 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY END USER, 2020–2028 (USD MILLION) 82
6.5 STEERABLE MICROCATHETERS 82
6.5.1 GROWING NUMBER OF IMAGE-GUIDED AND MINIMALLY INVASIVE MEDICAL PROCEDURES TO DRIVE MARKET 82
TABLE 29 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION) 83
TABLE 30 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 83
TABLE 31 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION) 84
TABLE 32 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY END USER, 2020–2028 (USD MILLION) 84
7 MICROCATHETERS MARKET, BY PRODUCT DESIGN 85
7.1 INTRODUCTION 86
TABLE 33 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 86
7.2 SINGLE-LUMEN MICROCATHETERS 86
7.2.1 INCREASING NUMBER OF TARGET MEDICAL PROCEDURES AND OPERATIONAL ADVANTAGES TO DRIVE MARKET 86
TABLE 34 MICROCATHETERS MARKET FOR SINGLE-LUMEN MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION) 87
7.3 DUAL AND MULTI-LUMEN MICROCATHETERS 87
7.3.1 IMPROVED SURGICAL PRECISION AND INCREASED ADOPTION IN COMPLEX VASCULAR PROCEDURES TO DRIVE MARKET 87
TABLE 35 MICROCATHETERS MARKET FOR DUAL AND MULTI-LUMEN MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION) 88
8 MICROCATHETERS MARKET, BY APPLICATION 89
8.1 INTRODUCTION 90
TABLE 36 MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 90
8.2 CARDIOVASCULAR APPLICATIONS 91
8.2.1 EFFECTIVE DEVICE PLACEMENT DURING MINIMALLY INVASIVE PROCEDURES AND CRITICAL CARDIAC SURGERIES TO DRIVE MARKET 91
TABLE 37 MICROCATHETERS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 91
8.3 NEUROVASCULAR APPLICATIONS 91
8.3.1 INCREASING INCIDENCE OF TARGET NEUROLOGICAL CONDITIONS TO DRIVE MARKET 91
TABLE 38 MICROCATHETERS MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 92
8.4 PERIPHERAL VASCULAR APPLICATIONS 92
8.4.1 RISING NUMBER OF DIAGNOSTIC AND INTERVENTIONAL PROCEDURES TO DRIVE MARKET 92
TABLE 39 MICROCATHETERS MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 93
8.5 UROLOGY APPLICATIONS 93
8.5.1 INCREASING PREVALENCE OF UROLOGICAL DISORDERS AND ADVANCEMENTS IN MINIMALLY INVASIVE TECHNIQUES TO DRIVE MARKET 93
TABLE 40 MICROCATHETERS MARKET FOR UROLOGY APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 94
8.6 ONCOLOGY APPLICATIONS 94
8.6.1 INCREASING CLINICAL RESEARCH ON MINIMALLY INVASIVE CANCER TREATMENT TO DRIVE MARKET 94
TABLE 41 MICROCATHETERS MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 95
8.7 OTOLARYNGOLOGY APPLICATIONS 95
8.7.1 INCREASED NEED FOR DELICATE ACCESS AND PRECISE NAVIGATION IN DIAGNOSIS TO DRIVE MARKET 95
TABLE 42 MICROCATHETERS MARKET FOR OTOLARYNGOLOGY APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 96
8.8 OTHER APPLICATIONS 96
TABLE 43 MICROCATHETERS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2028 (USD MILLION) 97
9 MICROCATHETERS MARKET, BY END USER 98
9.1 INTRODUCTION 99
TABLE 44 MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 99
9.2 HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS 99
9.2.1 LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO DRIVE MARKET 99
TABLE 45 MICROCATHETERS MARKET FOR HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS, BY REGION, 2020–2028 (USD MILLION) 100
9.3 AMBULATORY CARE CENTERS 100
9.3.1 GROWING PATIENT SUBMISSIONS FOR DIAGNOSTIC PROCEDURES IN EMERGING ECONOMIES TO DRIVE MARKET 100
TABLE 46 MICROCATHETERS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2020–2028 (USD MILLION) 101
 
10 MICROCATHETERS MARKET, BY REGION 102
10.1 INTRODUCTION 103
TABLE 47 MICROCATHETERS MARKET, BY REGION, 2020–2028 (USD MILLION) 103
10.2 NORTH AMERICA 104
FIGURE 28 NORTH AMERICA: MICROCATHETERS MARKET SNAPSHOT 104
10.2.1 RECESSION IMPACT: NORTH AMERICA 105
TABLE 48 NORTH AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 105
TABLE 49 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 106
TABLE 50 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 106
TABLE 51 NORTH AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 107
TABLE 52 NORTH AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 107
10.2.2 US 108
10.2.2.1 US to dominate North American microcatheters market during forecast period 108
TABLE 53 US: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 108
10.2.3 CANADA 108
10.2.3.1 Increasing prevalence of target diseases and high demand for timely diagnosis to drive market 108
TABLE 54 CANADA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 109
10.3 EUROPE 109
10.4 RECESSION IMPACT: EUROPE 109
TABLE 55 EUROPE: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 110
TABLE 56 EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 110
TABLE 57 EUROPE: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 111
TABLE 58 EUROPE: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 111
TABLE 59 EUROPE: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 112
10.4.1 GERMANY 112
10.4.1.1 Increasing aging population and rising life expectancy to drive market 112
TABLE 60 GERMANY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 112
10.4.2 FRANCE 113
10.4.2.1 Significant evolution of healthcare sector and growth in geriatric population to drive market 113
TABLE 61 FRANCE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 113
10.4.3 UK 113
10.4.3.1 High burden of chronic diseases and large volumes of surgeries to drive market 113
TABLE 62 UK: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 114
10.4.4 ITALY 114
10.4.4.1 Increasing geriatric population to drive market 114
TABLE 63 ITALY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 114
10.4.5 SPAIN 115
10.4.5.1 Increasing technological developments in healthcare sector to drive market 115
TABLE 64 SPAIN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 115
10.4.6 REST OF EUROPE 115
TABLE 65 REST OF EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 116
10.5 ASIA PACIFIC 116
10.6 RECESSION IMPACT: ASIA PACIFIC 116
FIGURE 29 ASIA PACIFIC: MICROCATHETERS MARKET SNAPSHOT 117
TABLE 66 ASIA PACIFIC: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 118
TABLE 67 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 118
TABLE 68 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 118
TABLE 69 ASIA PACIFIC: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 119
TABLE 70 ASIA PACIFIC: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 119
10.6.1 JAPAN 119
10.6.1.1 Increasing geriatric population and surgical procedures to drive market 119
TABLE 71 JAPAN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 120
10.6.2 CHINA 120
10.6.2.1 Growing prevalence of chronic disorders and developing healthcare infrastructure to drive market 120
TABLE 72 CHINA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 121
10.6.3 INDIA 122
10.6.3.1 Increasing target patient population with rising availability of advanced surgical treatments to drive market 122
TABLE 73 INDIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 122
10.6.4 AUSTRALIA 122
10.6.4.1 Developing healthcare sector and increasing availability of advanced surgical treatments to drive market 122
TABLE 74 AUSTRALIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 123
10.6.5 SOUTH KOREA 123
10.6.5.1 Growing target patient population to drive market 123
TABLE 75 SOUTH KOREA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 123
10.6.6 REST OF ASIA PACIFIC 124
TABLE 76 REST OF ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 124
10.7 LATIN AMERICA 124
10.8 RECESSION IMPACT: LATIN AMERICA 125
TABLE 77 LATIN AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 125
TABLE 78 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 125
TABLE 79 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 126
TABLE 80 LATIN AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 126
TABLE 81 LATIN AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 127
10.8.1 BRAZIL 127
10.8.1.1 Developing healthcare sector and increasing availability of advanced surgical treatments to drive market 127
TABLE 82 BRAZIL: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 127
10.8.2 MEXICO 128
10.8.2.1 Favorable government initiatives and rapidly growing healthcare sector to drive market 128
TABLE 83 MEXICO: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 128
10.9 MIDDLE EAST & AFRICA 128
10.9.1 INCREASING FOCUS OF MARKET PLAYERS AND ONGOING ECONOMIC GROWTH TO DRIVE MARKET 128
10.10 RECESSION IMPACT: MIDDLE EAST & AFRICA 129
TABLE 84 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 129
TABLE 85 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION) 130
TABLE 86 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 130
TABLE 87 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION) 131
 
11 COMPETITIVE LANDSCAPE 132
11.1 OVERVIEW 132
11.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS 132
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MICROCATHETERS MARKET 133
TABLE 88 OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MICROCATHETERS MARKET 133
11.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS 134
FIGURE 30 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN MICROCATHETERS MARKET 135
11.4 MARKET RANKING ANALYSIS 135
FIGURE 31 MICROCATHETERS MARKET RANKING, BY KEY PLAYER (2022) 136
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 138
11.5.1 STARS 138
11.5.2 EMERGING LEADERS 138
11.5.3 PERVASIVE PLAYERS 138
11.5.4 PARTICIPANTS 138
FIGURE 32 MICROCATHETERS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 139
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 140
11.6.1 PROGRESSIVE COMPANIES 140
11.6.2 STARTING BLOCKS 140
11.6.3 RESPONSIVE COMPANIES 140
11.6.4 DYNAMIC COMPANIES 140
FIGURE 33 MICROCATHETERS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/ SMES, 2022 141
11.7 COMPANY FOOTPRINT 142
TABLE 89 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN MICROCATHETERS MARKET 142
TABLE 90 COMPANY PRODUCT FOOTPRINT 143
TABLE 91 COMPANY GEOGRAPHICAL FOOTPRINT 144
11.8 COMPETITIVE SCENARIOS AND TRENDS 145
TABLE 92 KEY PRODUCT LAUNCHES 145
TABLE 93 KEY DEALS 146
TABLE 94 OTHER KEY DEVELOPMENTS 147
12 COMPANY PROFILES 148
12.1 KEY PLAYERS 148
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 MEDTRONIC 148
TABLE 95 MEDTRONIC: COMPANY OVERVIEW 148
FIGURE 34 MEDTRONIC: COMPANY SNAPSHOT (2022) 149
12.1.2 BOSTON SCIENTIFIC CORPORATION 152
TABLE 96 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 152
FIGURE 35 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 153
12.1.3 TERUMO MEDICAL CORPORATION 157
TABLE 97 TERUMO MEDICAL CORPORATION: COMPANY OVERVIEW 157
FIGURE 36 TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT (2022) 158
12.1.4 TELEFLEX INCORPORATED 162
TABLE 98 TELEFLEX INCORPORATED: COMPANY OVERVIEW 162
FIGURE 37 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022) 163
12.1.5 MERIT MEDICAL SYSTEMS, INC. 167
TABLE 99 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW 167
FIGURE 38 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2022) 168
12.1.6 ASAHI INTECC CO., LTD. 171
TABLE 100 ASAHI INTECC CO., LTD.: COMPANY OVERVIEW 171
FIGURE 39 ASAHI INTECC CO., LTD.: COMPANY SNAPSHOT (2022) 172
12.1.7 STRYKER 175
TABLE 101 STRYKER: COMPANY OVERVIEW 175
FIGURE 40 STRYKER: COMPANY SNAPSHOT (2022) 176
12.1.8 SURMODICS, INC. 178
TABLE 102 SURMODICS, INC.: COMPANY OVERVIEW 178
FIGURE 41 SURMODICS, INC.: COMPANY SNAPSHOT (2022) 179
12.1.9 CARDINAL HEALTH, INC. 181
TABLE 103 CARDINAL HEALTH, INC.: COMPANY OVERVIEW 181
FIGURE 42 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022) 182
12.1.10 JOHNSON & JOHNSON 184
TABLE 104 JOHNSON & JOHNSON: COMPANY OVERVIEW 184
FIGURE 43 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022) 185
12.1.11 GUERBET LLC 188
TABLE 105 GUERBET LLC: COMPANY OVERVIEW 188
FIGURE 44 GUERBET LLC: COMPANY SNAPSHOT (2022) 189
12.1.12 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD 191
TABLE 106 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW 191
FIGURE 45 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT (2022) 192
12.1.13 BECTON, DICKINSON AND COMPANY 194
TABLE 107 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 194
FIGURE 46 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 195
12.1.14 PENUMBRA, INC. 197
TABLE 108 PENUMBRA, INC.: COMPANY OVERVIEW 197
FIGURE 47 PENUMBRA, INC.: COMPANY SNAPSHOT (2022) 198
12.1.15 KANEKA CORPORATION 200
TABLE 109 KANEKA CORPORATION: COMPANY OVERVIEW 200
FIGURE 48 KANEKA CORPORATION: COMPANY SNAPSHOT (2022) 201
12.1.16 ANGIODYNAMICS, INC. 203
TABLE 110 ANGIODYNAMICS, INC.: COMPANY OVERVIEW 203
FIGURE 49 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT (2022) 204
12.1.17 BIOCARDIA INC. 206
TABLE 111 BIOCARDIA INC.: COMPANY OVERVIEW 206
12.2 OTHER PLAYERS 208
12.2.1 MILLAR, INC. 208
12.2.2 BAYLIS MEDICAL COMPANY, INC. 209
12.2.3 EMBOLX, INC. 210
12.2.4 ACANDIS GMBH 211
12.2.5 ACROSTAK 212
12.2.6 COOK MEDICAL 213
12.2.7 REFLOW MEDICAL, INC. 214
12.2.8 TZ MEDICAL, INC. 215
12.2.9 ORBUSNEICH MEDICAL 216
12.2.10 SPARTAN MICRO, INC. 217
12.2.11 TRANSIT SCIENTIFIC 218
12.2.12 TOKAI MEDICAL PRODUCTS 219
12.2.13 LIBATAPE PHARMACEUTICAL CO., LTD 220
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 221
13.1 DISCUSSION GUIDE 221
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 227
13.3 CUSTOMIZATION OPTIONS 229
13.4 RELATED REPORTS 229
13.5 AUTHOR DETAILS 230

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（oncology）の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15　10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.